Plante Moran Financial Advisors’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.21K | Buy |
+8
| New | +$4.49K | ﹤0.01% | 662 |
|
|
2026
Q1 | – | Sell |
-50
| Closed | -$33.8K | – | 806 |
|
|
2025
Q4 | $33.8K | Hold |
50
| – | – | ﹤0.01% | 372 |
|
|
2025
Q3 | $31.9K | Hold |
50
| – | – | ﹤0.01% | 401 |
|
|
2025
Q2 | $26.8K | Sell |
50
-100
| -67% | -$47.8K | ﹤0.01% | 442 |
|
|
2025
Q1 | $63K | Hold |
150
| – | – | 0.01% | 303 |
|
|
2024
Q4 | $62K | Hold |
150
| – | – | 0.01% | 314 |
|
|
2024
Q3 | $75.8K | Hold |
150
| – | – | 0.01% | 324 |
|
|
2024
Q2 | $73.1K | Sell |
150
-15
| -9% | -$7.53K | 0.01% | 282 |
|
|
2024
Q1 | $89.1K | Buy |
165
+146
| +768% | +$79.8K | 0.01% | 265 |
|
|
2023
Q4 | $10.5K | Buy |
+19
| New | +$8.92K | ﹤0.01% | 550 |
|
|
2022
Q3 | – | Sell |
-14
| Closed | -$5K | – | 951 |
|
|
2022
Q2 | $5K | Buy |
14
+4
| +40% | +$1.63K | ﹤0.01% | 714 |
|
|
2022
Q1 | $5K | Sell |
10
-9
| -47% | -$4.73K | ﹤0.01% | 678 |
|
|
2021
Q4 | $13K | Buy |
19
+1
| +6% | +$628 | ﹤0.01% | 635 |
|
|
2021
Q3 | $11K | Buy |
+18
| New | +$12.1K | ﹤0.01% | 671 |
|
|
2021
Q2 | – | Sell |
-647
| Closed | -$317K | – | 1008 |
|
|
2021
Q1 | $317K | Buy |
647
+550
| +567% | +$276K | 0.09% | 122 |
|
|
2020
Q4 | $48K | Sell |
97
-60
| -38% | -$26.8K | 0.01% | 368 |
|
|
2020
Q3 | $62K | Buy |
157
+60
| +62% | +$22.2K | 0.02% | 287 |
|
|
2020
Q2 | $32K | Hold |
97
| – | – | 0.01% | 354 |
|
|
2020
Q1 | $23K | Buy |
97
+66
| +213% | +$17.2K | 0.01% | 364 |
|
|
2019
Q4 | $8K | Buy |
+31
| New | +$8.17K | ﹤0.01% | 568 |
|
|
2019
Q3 | – | Sell |
-250
| Closed | -$69K | – | 875 |
|
|
2019
Q2 | $69K | Buy |
250
+100
| +67% | +$24.6K | 0.02% | 275 |
|
|
2019
Q1 | $34K | Buy |
+150
| New | +$31K | 0.01% | 399 |
|
|
2018
Q3 | – | Sell |
-22
| Closed | -$5K | – | 797 |
|
|
2018
Q2 | $5K | Sell |
22
-15
| -41% | -$3.09K | ﹤0.01% | 631 |
|
|
2018
Q1 | $7K | Sell |
37
-9
| -20% | -$1.66K | ﹤0.01% | 662 |
|
|
2017
Q4 | $7K | Buy |
46
+24
| +109% | +$3.78K | ﹤0.01% | 651 |
|
|
2017
Q3 | $3K | Hold |
22
| – | – | ﹤0.01% | 698 |
|
|
2017
Q2 | $4K | Hold |
22
| – | – | ﹤0.01% | 693 |
|
|
2017
Q1 | $3K | Sell |
22
-33
| -60% | -$4.55K | ﹤0.01% | 760 |
|
|
2016
Q4 | $6K | Buy |
55
+10
| +22% | +$1.14K | ﹤0.01% | 674 |
|
|
2016
Q3 | $5K | Hold |
45
| – | – | ﹤0.01% | 695 |
|
|
2016
Q2 | $4K | Sell |
45
-103
| -70% | -$8.85K | ﹤0.01% | 675 |
|
|
2016
Q1 | $12K | Hold |
148
| – | – | 0.01% | 455 |
|
|
2015
Q4 | $11K | Hold |
148
| – | – | 0.01% | 558 |
|
|
2015
Q3 | $11K | Hold |
148
| – | – | 0.01% | 468 |
|
|
2015
Q2 | $9K | Hold |
148
| – | – | 0.01% | 540 |
|
|
2015
Q1 | $11K | Hold |
148
| – | – | 0.01% | 499 |
|
|
2014
Q4 | $11K | Buy |
+148
| New | +$10.4K | 0.01% | 518 |
|
Other funds holding IDXX
MBI
CGI
Plante Moran Financial Advisors's IDXX Position: Q2 2026 in Review
Plante Moran Financial Advisors opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 8 shares worth $4.21K. The stake represents ﹤0.01% of the portfolio and ranks #662 among its holdings. This is a return to the name: Plante Moran Financial Advisors previously reported a position in IDXX as recently as Q4 2025.
Plante Moran Financial Advisors first reported a position in IDXX in Q4 2014 and has held it in 37 quarters since. The position peaked at $317K in Q1 2021. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Plante Moran Financial Advisors held 8 shares of Idexx Laboratories worth $4.21K as of Q2 2026.
- Idexx Laboratories was a new Plante Moran Financial Advisors position in Q2 2026.
- Idexx Laboratories made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #662 holding.
- Plante Moran Financial Advisors first reported a position in Idexx Laboratories in Q4 2014 and has held it in 37 quarters since.
- Plante Moran Financial Advisors's Idexx Laboratories position peaked at $317K in Q1 2021.
- 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.